Literature DB >> 28509347

Domain-specific cognitive impairment in non-demented Parkinson's disease psychosis.

Jared T Hinkle1,2, Kate Perepezko2, Catherine C Bakker3, Ted M Dawson3,4,5,6,7, Vanessa Johnson4, Zoltan Mari3,4, Cherie L Marvel2,8, Kelly A Mills4, Alexander Pantelyat3,4, Olga Pletnikova3,9, Liana S Rosenthal3,4, Melissa D Shepard2, Daniel A Stevens1,2, Juan C Troncoso3,9, Jiangxia Wang10, Gregory M Pontone2,3.   

Abstract

INTRODUCTION: In Parkinson's disease (PD), psychosis is associated with cognitive impairment that may be more profound in particular cognitive domains. Our goal was to determine whether psychosis in non-demented PD participants is associated with domain-specific cognitive impairment on the Mini-Mental State Exam (MMSE).
METHODS: The Morris K. Udall Parkinson's Disease Research Center of Excellence Longitudinal Study at Johns Hopkins is a prospective study that was initiated in 1998. Clinical assessments are conducted at two-year intervals at the Johns Hopkins Hospital. We analyzed data from 137 enrolled participants with idiopathic PD. Psychosis diagnoses were established by psychiatrist interview per DSM-IV criteria. An incident dementia diagnosis resulted in exclusion from analysis for that evaluation and any future evaluations in that participant. We used logistic regression with generalized estimated equations (GEE) to model the time-varying relationship between MMSE subscale scores and psychosis, adjusting for potential confounding variables identified through univariable analysis.
RESULTS: Thirty-one unique psychosis cases were recorded among non-demented participants. Fifty total evaluations with psychosis present were analyzed. In multivariable regressions, psychosis was associated with lower scores on the orientation (relative odds ratio, rOR: 0.73; 95% CI: 0.58-0.93; p = 0.011), language (rOR: 0.64; 95% CI: 0.48-0.86; p = 0.003), and intersecting pentagon (rOR: 0.43; 95% CI: 0.20-0.92 p = 0.030) subscales of the MMSE.
CONCLUSIONS: In PD, executive dysfunction, disorientation, and impaired language comprehension may be associated with psychosis. Our findings suggest that the corresponding MMSE subscales may be useful in identifying participants with a higher likelihood of developing psychosis.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MMSE; Parkinson's disease; cognitive domains; cognitive impairment; hallucinations; psychosis

Mesh:

Year:  2017        PMID: 28509347      PMCID: PMC5698175          DOI: 10.1002/gps.4736

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  26 in total

1.  Risk factors for nursing home placement in advanced Parkinson's disease.

Authors:  C G Goetz; G T Stebbins
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

2.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 3.  Cognitive and neuroanatomical correlates of neuropsychiatric symptoms in Parkinson's disease: A systematic review.

Authors:  Hamad Alzahrani; Annalena Venneri
Journal:  J Neurol Sci       Date:  2015-06-20       Impact factor: 3.181

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  Cognitive correlates of hallucinations and delusions in Parkinson's disease.

Authors:  Stewart A Factor; Michael K Scullin; Ann B Sollinger; Julia O Land; Cathy Wood-Siverio; Lavezza Zanders; Alan Freeman; Donald L Bliwise; William M McDonald; Felicia C Goldstein
Journal:  J Neurol Sci       Date:  2014-10-23       Impact factor: 3.181

6.  Longitudinal outcome of Parkinson's disease patients with psychosis.

Authors:  S A Factor; P J Feustel; J H Friedman; C L Comella; C G Goetz; R Kurlan; M Parsa; R Pfeiffer
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

7.  The neuropsychiatric profile of Parkinson's disease subjects with and without mild cognitive impairment.

Authors:  Roberto Monastero; Paola Di Fiore; Giusi D Ventimiglia; Rosolino Camarda; Cecilia Camarda
Journal:  J Neural Transm (Vienna)       Date:  2013-02-12       Impact factor: 3.575

Review 8.  Epidemiology of psychosis in Parkinson's disease.

Authors:  Gilles Fénelon; Guido Alves
Journal:  J Neurol Sci       Date:  2009-09-08       Impact factor: 3.181

9.  An overview of longitudinal data analysis methods for neurological research.

Authors:  Joseph J Locascio; Alireza Atri
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-10-26

Review 10.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

Authors:  C H Williams-Gray; T Foltynie; C E G Brayne; T W Robbins; R A Barker
Journal:  Brain       Date:  2007-05-29       Impact factor: 13.501

View more
  2 in total

1.  Remote self-administration of digital cognitive tests using the Brief Assessment of Cognition: Feasibility, reliability, and sensitivity to subjective cognitive decline.

Authors:  Alexandra S Atkins; Michael S Kraus; Matthew Welch; Zhenhua Yuan; Heather Stevens; Kathleen A Welsh-Bohmer; Richard S E Keefe
Journal:  Front Psychiatry       Date:  2022-08-24       Impact factor: 5.435

2.  Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.

Authors:  Alberto J Espay; Michael T Guskey; James C Norton; Bruce Coate; Joaquin A Vizcarra; Clive Ballard; Stewart A Factor; Joseph H Friedman; Anthony E Lang; Niccole J Larsen; Candace Andersson; Doral Fredericks; Daniel Weintraub
Journal:  Mov Disord       Date:  2018-11-02       Impact factor: 10.338

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.